Peer Review History
| Original SubmissionMarch 1, 2021 |
|---|
|
PONE-D-21-06771 Seed dressing with mefenpyr-diethyl as a safener for mesosulfuron-methyl application in wheat:the evaluation and mechanisms PLOS ONE Dear Dr. Yuan, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by July 21, 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Vijay Gahlaut, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you are reporting an analysis of a microarray, next-generation sequencing, or deep sequencing data set. PLOS requires that authors comply with field-specific standards for preparation, recording, and deposition of data in repositories appropriate to their field. Please upload these data to a stable, public repository (such as ArrayExpress, Gene Expression Omnibus (GEO), DNA Data Bank of Japan (DDBJ), NCBI GenBank, NCBI Sequence Read Archive, or EMBL Nucleotide Sequence Database (ENA)). In your revised cover letter, please provide the relevant accession numbers that may be used to access these data. For a full list of recommended repositories, see http://journals.plos.org/plosone/s/data-availability#loc-omics or http://journals.plos.org/plosone/s/data-availability#loc-sequencing. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The application of mefenpyr-diethyl as seed dresser in wheat is a novel approach and a quite promising technique to mitigate the adverse effects of mesosulfuron-methyl and in general of many herbicides to the crop. The subject of the study is interesting with high scientific and practical importance. The introduction is in accordance with the subject and correctly presented. Methodology of the study was clearly presented and was appropriate to the proposed objectives, allowing the repetition of the experiments and the protocols. The statistical analysis was clear. The obtained results have been analyzed and interpreted in accordance with the current methodology. The thorough analysis of the agronomic traits (GR50), dissipation, enzymic and transcriptomic assays resulted to a significant outcome. The discussion is appropriate, in the context of the results, and was conducted compared to other studies in the field. Authors are strongly encouraged to cite more articles about the agronomic value of seed dressing with safener, in order to increase the impact of their research. The scientific literature, to which the reporting was made, is recent and representative in the field. However, authors are kindly asked to answer: (1) why they applied mesosulfuron-methyl with/without mefenpyr-diethyl at 1-leaf stage of the wheat and the weed. It is quite uncommon in the field scale to spray herbicides in such early growth stage, (2) why they used plant height instead of plant fresh/dry weight in the dose-response assays, (3) why they mention weed resistance in the abstract without linking their results about the metabolic changes in the plants with existing literature about ALS resistance mechanisms. Moreover, the review of the article revealed some minor issues, which are noted below. Keywords: safener Line 23: It is probably useful to refer to the seed dressing of wheat by writing ..the effect of wheat seed dressing.. Lines 36-37: Include the binomial names of the species in italics Line 37: “It could cause 50-80% yield loss of production in wheat producing regions”. Which is the density that may lead to such yield loss? Line 38: “were”. I believe that remain poor until today, so please edit appropriately. Line 49: increase Line 53: involves Lines 54-56: Please rephrase the sentence “However..safeners”. Lines 76-77: “No suspected resistant or susceptible to mesosulfuron-methyl of Taush’s goatgrass was found to the land owner”. Authors mention both lack of resistance and sensitivity to mesosulfuron-methyl. Which is correct? If the Tausch's goatgrass biotype is susceptible, then why is resistance mentioned? Which is the history of herbicide applications in the field? Was mesosulfuron-methyl consecutively applied in wheat every year? Line 86: mesosulfuron Lines 151/154: ANOVA Line 171: Authors mention here that GR50 refers to the 50% growth inhibition of plants, while previously it is noted as plant height inhibition. Which is correct? Line 290-291: You mean probably mesosulfuron-methyl and not mesulfuron-methyl Line 296: mefenpyr-diethyl Reviewer #2: Mesosulfuron-methyl is a specific herbicide to control Tausch’s goatgrass which is the most troublesome weeds in wheat fields in China. Without safener, mesosulfuron-methyl will cause certain damage to wheat. This manuscript reported the effect and mechanism of mefenpyr-diethyl as a safener for mesosulfuron-methyl application, and provided an alternative approach to reduce the crop injury and enhance the herbicide efficacy by seed dressing. In general, this manuscript is well organized and the finding is of great importance for weed management in wheat fields. To improve the quality and readability, some suggestions or comments are listed as the following: Line 19: need to add latin name for plant like wheat or Tausch’s goatgrass at the first time it is used in the abstract or the body of the paper. Line 20: suggest change “varieties” to “cultivars”. Line 24: suggest change “uncovered” to “disclosed”. Line 25: change “enzymic” to “enzymatic”. Line 28: suggest change “RLK-Pelle DLSV” to “RLK-Pelle_DLSV”. Line 36-37: Plant latin name should be italicized. Line 48: change “no reports” to “no report”. Line 49: change “increas” to “increase”, need to check the grammar and spelling throughout the manuscript. Line 51: delete “and increase the risk of phytotoxicity”. Line 61: delete “herbicide”. Line 93-95: in table 1, need to check the dose of the treatment. Line 112-122: Why did the authors not to study the mechanisms of spaying both mesosulfuron-methyl and mefenpyr-diethyl for comparison and concentrate only on seed dressing? Line 151 and after: change “ANVOA” to “ANOVA”. Line 167: in table 2, the ratio of GR50 should be listed in the table. Line 205-237: For transcriptome analysis, common sequence results and gene annotations maybe omitted, the authors should focus on DEGs and their dynamics related to certain pathways like stress responses, transcription factors and protein kinases which were induced by mefenpyr-diethyl. Line 239-240: For consistency, gene name like UGTs and ABCs should change position with their definitions. Line 278 and after: the discussion section should be concise and informative, for practical use of seed dressing in weed management, the authors need to analyze the common or difference between this study and other previous studies, based on the evaluation of effects, risks or potential usage in current advances, the authors could make an objective and rigorous conclusion. Line 293: change “in” to “between”. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-06771R1 Seed dressing with mefenpyr-diethyl as a safener for mesosulfuron-methyl application in wheat:the evaluation and mechanisms PLOS ONE Dear Dr. Yuan, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by August 15, 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Vijay Gahlaut, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: The authors have made some corrections according to the editor and reviewers’ suggestions. I recommend it to be published and suggest minor revisions to improve the quality and readability. Here are some revisions suggested: Line 38: need to rephrase “yield loss of production in wheat producing regions”. Line 147: pay attention to the format of “2-∆∆Ct”. Line 172: delete “of plants”. Line 226: lowercase for “L” in “alpha-Linolenic acid metabolism”. Line 250: check the spelling “mephenpr-diethyl”. Line 257: check the spelling “WORKY”. Line 278: check the style of citation “Duhoux et al. (2017)” throughout the manuscript, which differ to line 59,100,118,300,318…… Line 283: suggest change “researches” to “studies”. Line 320: need to rephrase the sentence “……could be evidence.” Line 355: unified the citation of “S2 Fig” or “Fig S3”, and table? Line 378: change “enzymic” to “enzymatic”. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Seed dressing with mefenpyr-diethyl as a safener for mesosulfuron-methyl application in wheat:the evaluation and mechanisms PONE-D-21-06771R2 Dear Dr. Yuan, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Vijay Gahlaut, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-06771R2 Seed dressing with mefenpyr-diethyl as a safener for mesosulfuron-methyl application in wheat: the evaluation and mechanisms. Dear Dr. Yuan: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Vijay Gahlaut Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .